Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Diagnostics (Basel) ; 13(11)2023 Jun 02.
Article in English | MEDLINE | ID: covidwho-20235054

ABSTRACT

BACKGROUND AND MOTIVATION: Lung computed tomography (CT) techniques are high-resolution and are well adopted in the intensive care unit (ICU) for COVID-19 disease control classification. Most artificial intelligence (AI) systems do not undergo generalization and are typically overfitted. Such trained AI systems are not practical for clinical settings and therefore do not give accurate results when executed on unseen data sets. We hypothesize that ensemble deep learning (EDL) is superior to deep transfer learning (TL) in both non-augmented and augmented frameworks. METHODOLOGY: The system consists of a cascade of quality control, ResNet-UNet-based hybrid deep learning for lung segmentation, and seven models using TL-based classification followed by five types of EDL's. To prove our hypothesis, five different kinds of data combinations (DC) were designed using a combination of two multicenter cohorts-Croatia (80 COVID) and Italy (72 COVID and 30 controls)-leading to 12,000 CT slices. As part of generalization, the system was tested on unseen data and statistically tested for reliability/stability. RESULTS: Using the K5 (80:20) cross-validation protocol on the balanced and augmented dataset, the five DC datasets improved TL mean accuracy by 3.32%, 6.56%, 12.96%, 47.1%, and 2.78%, respectively. The five EDL systems showed improvements in accuracy of 2.12%, 5.78%, 6.72%, 32.05%, and 2.40%, thus validating our hypothesis. All statistical tests proved positive for reliability and stability. CONCLUSION: EDL showed superior performance to TL systems for both (a) unbalanced and unaugmented and (b) balanced and augmented datasets for both (i) seen and (ii) unseen paradigms, validating both our hypotheses.

2.
Pharmaceuticals (Basel) ; 16(1)2022 Dec 22.
Article in English | MEDLINE | ID: covidwho-2310459

ABSTRACT

This research develops the TB/non-TB detection and drug-resistant categorization diagnosis decision support system (TB-DRC-DSS). The model is capable of detecting both TB-negative and TB-positive samples, as well as classifying drug-resistant strains and also providing treatment recommendations. The model is developed using a deep learning ensemble model with the various CNN architectures. These architectures include EfficientNetB7, mobileNetV2, and Dense-Net121. The models are heterogeneously assembled to create an effective model for TB-DRC-DSS, utilizing effective image segmentation, augmentation, and decision fusion techniques to improve the classification efficacy of the current model. The web program serves as the platform for determining if a patient is positive or negative for tuberculosis and classifying several types of drug resistance. The constructed model is evaluated and compared to current methods described in the literature. The proposed model was assessed using two datasets of chest X-ray (CXR) images collected from the references. This collection of datasets includes the Portal dataset, the Montgomery County dataset, the Shenzhen dataset, and the Kaggle dataset. Seven thousand and eight images exist across all datasets. The dataset was divided into two subsets: the training dataset (80%) and the test dataset (20%). The computational result revealed that the classification accuracy of DS-TB against DR-TB has improved by an average of 43.3% compared to other methods. The categorization between DS-TB and MDR-TB, DS-TB and XDR-TB, and MDR-TB and XDR-TB was more accurate than with other methods by an average of 28.1%, 6.2%, and 9.4%, respectively. The accuracy of the embedded multiclass model in the web application is 92.6% when evaluated with the test dataset, but 92.8% when evaluated with a random subset selected from the aggregate dataset. In conclusion, 31 medical staff members have evaluated and utilized the online application, and the final user preference score for the web application is 9.52 out of a possible 10.

3.
Biomed Signal Process Control ; : 104445, 2022 Nov 30.
Article in English | MEDLINE | ID: covidwho-2239179

ABSTRACT

Background: and ObjectivIn the current COVID-19 outbreak, efficient testing of COVID-19 individuals has proven vital to limiting and arresting the disease's accelerated spread globally. It has been observed that the severity and mortality ratio of COVID-19 affected patients is at greater risk because of chronic pulmonary diseases. This study looks at radiographic examinations exploiting chest X-ray images (CXI), which have become one of the utmost feasible assessment approaches for pulmonary disorders, including COVID-19. Deep Learning(DL) remains an excellent image classification method and framework; research has been conducted to predict pulmonary diseases with COVID-19 instances by developing DL classifiers with nine class CXI. However, a few claim to have strong prediction results; because of noisy and small data, their recommended DL strategies may suffer from significant deviation and generality failures. Methods: Therefore, a unique CNN model(PulDi-COVID) for detecting nine diseases (atelectasis, bacterial-pneumonia, cardiomegaly, covid19, effusion, infiltration, no-finding, pneumothorax, viral-Pneumonia) using CXI has been proposed using the SSE algorithm. Several tranfer-learning models: VGG16, ResNet50, VGG19, DenseNet201, MobileNetV2, NASNetMobile, ResNet152V2, DenseNet169 are trained on CXI of chronic lung diseases and COVID-19 instances. Given that the proposed thirteen SSE ensemble models solved DL's constraints by making predictions with different classifiers rather than a single, we present PulDi-COVID, an ensemble DL model that combines DL with ensemble learning. The PulDi-COVID framework is created by incorporating various snapshots of DL models, which have spearheaded chronic lung diseases with COVID-19 cases identification process with a deep neural network produced CXI by applying a suggested SSE method. That is familiar with the idea of various DL perceptions on different classes. Results: PulDi-COVID findings were compared to thirteen existing studies for nine-class classification using COVID-19. Test results reveal that PulDi-COVID offers impressive outcomes for chronic diseases with COVID-19 identification with a 99.70% accuracy, 98.68% precision, 98.67% recall, 98.67% F1 score, lowest 12 CXIs zero-one loss, 99.24% AUC-ROC score, and lowest 1.33% error rate. Overall test results are superior to the existing Convolutional Neural Network(CNN). To the best of our knowledge, the observed results for nine-class classification are significantly superior to the state-of-the-art approaches employed for COVID-19 detection. Furthermore, the CXI that we used to assess our algorithm is one of the larger datasets for COVID detection with pulmonary diseases. Conclusion: The empirical findings of our suggested approach PulDi-COVID show that it outperforms previously developed methods. The suggested SSE method with PulDi-COVID can effectively fulfill the COVID-19 speedy detection needs with different lung diseases for physicians to minimize patient severity and mortality.

4.
2022 FORTEI-International Conference on Electrical Engineering, FORTEI-ICEE 2022 ; : 76-80, 2022.
Article in English | Scopus | ID: covidwho-2191776

ABSTRACT

Coronavirus Disease of 2019 (COVID-19) has a high transmission and death rate. It is important to diagnose COVID-19 accurately and distinguish it clearly from other common lung diseases, e.g., pneumonia. Both diseases are detectable from chest X-Ray images. Therefore, an ensemble deep learning model is applied for multiclass classification of COVID-19, pneumonia, or normal lungs based on chest X-Ray images. ResNet50, VGG16, and InceptionV3 pretrained CNN models are employed to form an ensemble model. The chest X-Ray images are preprocessed in three steps, i.e., cropping, resizing, and normalization. Then, the pretrained models are trained with a new classifier at the top layer of the model. After the classifier is trained, then the pretrained ResNet50, VGG16, and InceptionV3 are fine-Tuned. Lastly, the decisions from each model are assembled using Soft Voting. The ensemble deep learning model which produces the best result, which is formed by combining pretrained and fine-Tuned ResNet50, VGG16, and InceptionV3 models, results weighted accuracy of 0.9752, weighted sensitivity of 0.9612, and weighted specificity of 0.9804. © 2022 IEEE.

5.
1st International Conference on Ambient Intelligence in Health Care, ICAIHC 2021 ; 317:241-249, 2023.
Article in English | Scopus | ID: covidwho-2173921

ABSTRACT

New coronavirus (COVID-19), which first appeared in Wuhan City and is now rapidly disseminating worldwide, may be predicted, diagnosed, and treated with the help of cutting-edge medical technology, such as artificial intelligence and machine learning algorithms. To detect COVID-19, we suggested an Ensemble deep learning method with an attention mechanism. The suggested approach uses an ensemble of RNN and CNN to extract features from data from diverse sources, such as CT scan pictures and blood test results. For image and video processing, CNNs are the most effective. RNNs, on the other hand, use text and speech data to extract features. Further, an attention mechanism is used to determine which features are most relevant for classification. Finally, the deep learning network utilizes the selected features for detection and prediction. As a result, data can be used to forecast future medical needs. © 2023, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

6.
Intelligent Automation and Soft Computing ; 35(2):2383-2398, 2023.
Article in English | Scopus | ID: covidwho-1965089

ABSTRACT

Internet of things (IoT) has brought a greater transformation in health-care sector thereby improving patient care, minimizing treatment costs. The pre-sent method employs classical mechanisms for extracting features and a regression model for prediction. These methods have failed to consider the pollution aspects involved during COVID 19 prediction. Utilizing Ensemble Deep Learning and Framingham Feature Extraction (FFE) techniques, a smart health-care system is introduced for COVID-19 pandemic disease diagnosis. The Col-lected feature or data via predictive mechanisms to form pollution maps. Those maps are used to implement real-time countermeasures, such as storing the extracted data or feature in a Cloud server to minimize concentrations of air pol-lutants. Once integrated with patient management systems, this solution would minimize pollution emitted via patient’s sensors by offering spaces in the cloud server when pollution thresholds are reached. Second, the Gini Index factor information gain technique eliminates unimportant and redundant attributes while selecting the most relevant, reducing computing overhead and optimizing system performance. Finally, the COVID-19 disease prognosis ensemble deep learning-based classifier is constructed. Experimental analysis is planned to measure the prediction accuracy, error, precision and recall for different numbers of patients. Experimental results show that prediction accuracy is improved by 8%, error rate was reduced by 47% and prediction time is minimized by 36% compared to existing methods. © 2023, Tech Science Press. All rights reserved.

7.
APPLIED SCIENCES-BASEL ; 12(13), 2022.
Article in English | Web of Science | ID: covidwho-1938675

ABSTRACT

Pneumonia is a life-threatening lung infection resulting from several different viral infections. Identifying and treating pneumonia on chest X-ray images can be difficult due to its similarity to other pulmonary diseases. Thus, the existing methods for predicting pneumonia cannot attain substantial levels of accuracy. This paper presents a computer-aided classification of pneumonia, coined Ensemble Learning (EL), to simplify the diagnosis process on chest X-ray images. Our proposal is based on Convolutional Neural Network (CNN) models, which are pretrained CNN models that have been recently employed to enhance the performance of many medical tasks instead of training CNN models from scratch. We propose to use three well-known CNNs (DenseNet169, MobileNetV2, and Vision Transformer) pretrained using the ImageNet database. These models are trained on the chest X-ray data set using fine-tuning. Finally, the results are obtained by combining the extracted features from these three models during the experimental phase. The proposed EL approach outperforms other existing state-of-the-art methods and obtains an accuracy of 93.91% and a F1-score of 93.88% on the testing phase.

8.
Brief Bioinform ; 22(6)2021 11 05.
Article in English | MEDLINE | ID: covidwho-1367012

ABSTRACT

Accurate prediction of immunogenic peptide recognized by T cell receptor (TCR) can greatly benefit vaccine development and cancer immunotherapy. However, identifying immunogenic peptides accurately is still a huge challenge. Most of the antigen peptides predicted in silico fail to elicit immune responses in vivo without considering TCR as a key factor. This inevitably causes costly and time-consuming experimental validation test for predicted antigens. Therefore, it is necessary to develop novel computational methods for precisely and effectively predicting immunogenic peptide recognized by TCR. Here, we described DLpTCR, a multimodal ensemble deep learning framework for predicting the likelihood of interaction between single/paired chain(s) of TCR and peptide presented by major histocompatibility complex molecules. To investigate the generality and robustness of the proposed model, COVID-19 data and IEDB data were constructed for independent evaluation. The DLpTCR model exhibited high predictive power with area under the curve up to 0.91 on COVID-19 data while predicting the interaction between peptide and single TCR chain. Additionally, the DLpTCR model achieved the overall accuracy of 81.03% on IEDB data while predicting the interaction between peptide and paired TCR chains. The results demonstrate that DLpTCR has the ability to learn general interaction rules and generalize to antigen peptide recognition by TCR. A user-friendly webserver is available at http://jianglab.org.cn/DLpTCR/. Additionally, a stand-alone software package that can be downloaded from https://github.com/jiangBiolab/DLpTCR.


Subject(s)
COVID-19 Drug Treatment , Epitopes/immunology , Peptides/immunology , Receptors, Antigen, T-Cell/immunology , SARS-CoV-2/immunology , Amino Acid Sequence/genetics , COVID-19/genetics , COVID-19/immunology , COVID-19/virology , Computer Simulation , Deep Learning , Epitopes/genetics , Humans , Peptides/genetics , Peptides/therapeutic use , Protein Binding/genetics , Receptors, Antigen, T-Cell/genetics , SARS-CoV-2/genetics , SARS-CoV-2/pathogenicity , Software
9.
Int J Multimed Inf Retr ; 10(1): 55-68, 2021.
Article in English | MEDLINE | ID: covidwho-1107898

ABSTRACT

With the recent spread of the SARS-CoV-2 virus, computer-aided diagnosis (CAD) has received more attention. The most important CAD application is to detect and classify pneumonia diseases using X-ray images, especially, in a critical period as pandemic of covid-19 that is kind of pneumonia. In this work, we aim to evaluate the performance of single and ensemble learning models for the pneumonia disease classification. The ensembles used are mainly based on fined-tuned versions of (InceptionResNet_V2, ResNet50 and MobileNet_V2). We collected a new dataset containing 6087 chest X-ray images in which we conduct comprehensive experiments. As a result, for a single model, we found out that InceptionResNet_V2 gives 93.52% of F1 score. In addition, ensemble of 3 models (ResNet50 with MobileNet_V2 with InceptionResNet_V2) shows more accurate than other ensembles constructed (94.84% of F1 score).

SELECTION OF CITATIONS
SEARCH DETAIL